BioSpace News Archive

Press Releases

Theratechnologies Unveils Study Design and Baseline Characteristics of PROMISE-US Trial of Ibalizumab in Heavily Treatment-Experienced People with HIV and Multidrug Resistance

October 17, 2024
·
6 min read
Press Releases

Biodexa’s MX-110 Continues to Show Promise in Recurrent Glioblastoma (rGBM), the Deadliest Brain Cancer

October 17, 2024
·
6 min read
Press Releases

Intra-Cellular Therapies to Host Third Quarter 2024 Financial Results Conference Call and Webcast

October 17, 2024
·
1 min read
Press Releases

Eterna Therapeutics and Factor Bioscience Announce Exclusive License and Collaboration Agreement to Accelerate Cell Therapy Development for Oncology, Autoimmune, and Rare Diseases

October 17, 2024
·
4 min read
Press Releases

Immutep Announces First-in-Human Phase I Study of IMP761 Progresses to Dose Escalation Portion of Trial

October 17, 2024
·
2 min read
Press Releases

Noema Pharma Announces NOE-105 (gemlapodect) Phase 2a Study in Tourette Syndrome met Primary and all Key Secondary Endpoints

October 17, 2024
·
4 min read
Press Releases

OmniaBio Announces Opening of New Commercial Manufacturing Facility in Canada, Bringing Life-Saving Cell and Gene Therapies to Patients

October 17, 2024
·
6 min read
News

Clarametyx Biosciences Announces Progress on Study of Antibody Therapy CMTX-101 for Infections Associated With Cystic Fibrosis

October 17, 2024
·
4 min read
Business

Alnylam to Webcast Conference Call Discussing Third Quarter 2024 Financial Results

October 17, 2024
·
1 min read
Business

Xaira Therapeutics Appoints Dr. Debbie Law as Chief Scientific Officer and Julia Tran as Chief People Officer

October 17, 2024
·
4 min read